340B Advocacy Alliance Bulletin
The Department of Health and Human Services Office of the General Counsel Dec.
Attorneys general in 27 states and Washington, D.C., today
The AHA, joined by four other national hospital groups and an organization of hospital pharmacists representing participants in the 340B drug pricing program, yesterday filed a federal lawsuit against the Department of Health and Human Services over the department’s failure to enforce program…
The Health Resources and Services Administration Dec.
The Health Resources and Services Administration today released its long-awaited
The AHA on Friday sent a letter to the Health Resources and Services Administration’s Office of Pharmacy Affairs urging the agency to order drug manufacturers and their vendor Kalderos to immediately halt their conversion of the 340B program to a back-end rebate program.
The AHA today submitted
The full U.S. Court of Appeals for the District of Columbia Circuit Oct. 16 denied AHA’s request to reconsider two decisions from this summer that upheld the Centers for Medicare & Medicaid Services’ cuts to payments for 340B drugs and for off-campus hospital outpatient clinic visits.
AHA urges HHS to stop drug companies’ refusal to provide required 340B discounts
In comments on OPPS proposed rule, AHA urges HHS to immediately reverse 340B cuts